Investor AB (Wallenberg Family) latest 13F portfolio: 7 holdings worth $14.4B as of Q2 2026.
Backtested since 2020: mirroring Investor AB's reported 13F equity holdings each quarter would have returned +152.1% versus +186.7%for the S&P 500 (+15.7% annualized). See the Performance tab for the full equity curve.
Investor: Wallenberg Family
Number of Assets: 7
Reporting Period: Q2 - 2026
Holdings at Report: $14,403,406,346
Return $ Since Report: -$165,863,177
Return % Since Report: -1.15%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mediwound Ltd. (MDWD) | Equity | 0% | 872,093 | 0.09% | $14.70 | $13.77 | $12,819,767 | $12,008,721 | -$811,046 | -6.33% |
| Cellebrite DI (CLBT) | Equity | +36.36% | 75,000 | 0.01% | $14.60 | $11.62 | $1,095,000 | $871,500 | -$223,500 | -20.41% |
| Verizon Communications Inc. (VZ) | Equity | 0% | 11,300 | 0.00% | $42.34 | $47.05 | $478,442 | $531,665 | +$53,223 | +11.12% |
| Nasdaq Inc. (NDAQ) | Equity | +0.10% | 58,439,208 | 31.98% | $78.82 | $94.70 | $4,606,178,375 | $5,534,192,998 | +$928,014,623 | +20.15% |
| Biomarin Pharmaceutical Inc. (BMRN) | Equity | 0% | 3,700 | 0.00% | $57.22 | $64.09 | $211,714 | $237,133 | +$25,419 | +12.01% |
| Astrazeneca PLC (AZN) | Equity | 0% | 51,587,810 | 67.92% | $189.62 | $168.44 | $9,782,080,532 | $8,689,192,777 | -$1,092,887,755 | -11.17% |
| Micron Technology Inc. (MU) | Equity | +100% | 470 | 0.00% | $1,154.29 | $1,081.65 | $542,516 | $508,376 | -$34,141 | -6.29% |